Stay updated on Pembrolizumab vs Standard Therapy in Glioblastoma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab vs Standard Therapy in Glioblastoma Clinical Trial page.

Latest updates to the Pembrolizumab vs Standard Therapy in Glioblastoma Clinical Trial page
- ChecktodayChange DetectedA dedicated Locations section was added listing study sites in Arizona and Minnesota, and the former separate Arizona Locations and Minnesota Locations subsections were removed.SummaryDifference0.3%

- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check29 days agoChange DetectedThis change is a minor revision update from v3.2.0 to v3.3.2 and does not modify study content, eligibility criteria, endpoints, or other user-facing information. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check36 days agoChange DetectedRemoved the government funding status notice about potential data updates and delays on the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check58 days agoChange DetectedNo substantive changes to core study information (eligibility, interventions, outcomes, or enrollment) are visible in the new screenshot; any differences appear cosmetic. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check79 days agoChange DetectedVersion bumped to v3.2.0 with an added government-operating-status notice; the previous v3.1.0 deletion indicates the page now reflects the updated version.SummaryDifference2%

- Check86 days agoChange DetectedUpdated page to version v3.1.0 and removed several topic categories (Electromagnetic Radiation, Magnetic Phenomena, Electromagnetic Phenomena), indicating a scope reduction and a new version label.SummaryDifference0.2%

Stay in the know with updates to Pembrolizumab vs Standard Therapy in Glioblastoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab vs Standard Therapy in Glioblastoma Clinical Trial page.